broad-spectrum HPV vaccine (Wuhan BravoVax/Shanghai BravoBio)

N/A

Report date: 2025/03/14 16:50:11

Base Information

Drug Namebroad-spectrum HPV vaccine (Wuhan BravoVax/Shanghai BravoBio)
Drug Alias Namebroad-spectrum HPV vaccine (National Institutes of Health/Johns Hopkins University)
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New ZealandMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Bravobio Co LtdWuhan Bravovax Co Ltd
Inactive CompaniesN/A
Active IndicationsPapillomavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A